Biobide Overview

  • Founded
  • 2005

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

Biobide General Information

Description

Developer of toxicity and efficacy assays intended to perform drug toxicity and efficacy tests. The company specializes in target validation, acute tox, teratotox, cardiotoxic, neurotoxic, disease model generation and kidney toxicity, thereby enabling its clients to maximize development and productivity and minimize the risks in the drug discovery processes to gain better insights into pre-clinical research and development.

Contact Information

Website
www.biobide.es
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Drug Discovery
Parent Company
Biat Group
Primary Office
  • Paseo Mikeletegui 56
  • Donostia
  • 20009 San Sebastian
  • Spain
+34 943 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biobide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 04-Jun-2014 00.000 Completed Generating Revenue
1. Early Stage VC 01-Jun-2005 00.000 00.000 Completed Startup
To view Biobide’s complete valuation and funding history, request access »

Biobide Executive Team (10)

Name Title Board Seat Contact Info
Victor Infante Ph.D President, Chairman & Co-Chief Executive Officer
José Martín Co-Chief Executive Officer & Board Member
Andoni Pacheco Co-Founder, General Manager & Board Member
Arantza Muriana Miralles Co-Founder, Research & Development Management Director & Board Member
You’re viewing 4 of 10 executive team members. Get the full list »

Biobide Board Members (4)

Name Representing Role Since
Andoni Pacheco Biobide Co-Founder, General Manager & Board Member 000 0000
José Martín Biobide Co-Chief Executive Officer & Board Member 000 0000
Victor Infante Ph.D Biobide President, Chairman & Co-Chief Executive Officer 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Biobide Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biobide Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Basque Venture Capital Management Venture Capital Minority 000 0000 000000 0
Genetrix Group Corporation Minority 000 0000 000000 0
Mondragon Corporation Minority 000 0000 000000 0
To view Biobide’s complete investors history, request access »

Ready to get started?

Request a free trial